55 related articles for article (PubMed ID: 25300229)
1. Reproducibility of histological subtyping of malignant pleural mesothelioma.
Brčić L; Jakopović M; Brčić I; Klarić V; Milošević M; Sepac A; Samaržija M; Seiwerth S
Virchows Arch; 2014 Dec; 465(6):679-85. PubMed ID: 25300229
[TBL] [Abstract][Full Text] [Related]
2. Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients.
Lamberti M; Capasso R; Lombardi A; Di Domenico M; Fiorelli A; Feola A; Perna AF; Santini M; Caraglia M; Ingrosso D
PLoS One; 2015; 10(8):e0135331. PubMed ID: 26262875
[TBL] [Abstract][Full Text] [Related]
3. Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.
Li Y; Salama AM; Baine MK; Bodd FM; Offin MD; Rekhtman N; Zauderer MG; Travis WD; Adusumilli PS; Sauter JL
Cancer Cytopathol; 2023 Aug; 131(8):495-506. PubMed ID: 37127928
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.
Roncella S; Laurent S; Fontana V; Ferro P; Franceschini MC; Salvi S; Varesano S; Boccardo S; Vigani A; Morabito A; Canessa PA; Giannoni U; Rosenberg I; Valentino A; Fedeli F; Merlo DF; Ceppi M; Riggio S; Romani M; Saverino D; Poggi A; Pistillo MP
Cancer Immunol Immunother; 2016 Aug; 65(8):909-17. PubMed ID: 27207606
[TBL] [Abstract][Full Text] [Related]
5. Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity.
Brcic L; Mathilakathu A; Walter RFH; Wessolly M; Mairinger E; Beckert H; Kreidt D; Steinborn J; Hager T; Christoph DC; Kollmeier J; Mairinger T; Wohlschlaeger J; Schmid KW; Borchert S; Mairinger FD
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917061
[TBL] [Abstract][Full Text] [Related]
6. Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor.
Salazar C; Kanter Md N; Abboud A
Cureus; 2018 Jun; 10(6):e2749. PubMed ID: 30109162
[TBL] [Abstract][Full Text] [Related]
7. New Immunohistochemical Markers for Pleural Mesothelioma Subtyping.
Di Stefano I; Alì G; Poma AM; Bruno R; Proietti A; Niccoli C; Zirafa CC; Melfi F; Mastromarino MG; Lucchi M; Fontanini G
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761312
[TBL] [Abstract][Full Text] [Related]
8. MesoGraph: Automatic profiling of mesothelioma subtypes from histological images.
Eastwood M; Sailem H; Marc ST; Gao X; Offman J; Karteris E; Fernandez AM; Jonigk D; Cookson W; Moffatt M; Popat S; Minhas F; Robertus JL
Cell Rep Med; 2023 Oct; 4(10):101226. PubMed ID: 37816348
[TBL] [Abstract][Full Text] [Related]
9. A deep learning-based model (DeepMPM) to help predict survival in patients with malignant pleural mesothelioma.
Li W; Zhang M; Cai S; Li S; Yang B; Zhou S; Pan Y; Xu S
Transl Cancer Res; 2023 Oct; 12(10):2887-2897. PubMed ID: 37969363
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study.
Akl Y; Kaddah S; Abdelhafeez A; Salah R; Lotayef M
Arch Med Sci; 2010 Dec; 6(6):926-31. PubMed ID: 22427768
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype.
Giusti L; Ciregia F; Bonotti A; Da Valle Y; Donadio E; Boldrini C; Foddis R; Giannaccini G; Mazzoni MR; Canessa PA; Cristaudo A; Lucacchini A
EuPA Open Proteom; 2016 Mar; 10():42-49. PubMed ID: 29900099
[TBL] [Abstract][Full Text] [Related]
12. Remarkable response to nivolumab in sarcomatoid malignant pleural mesothelioma with high PD-L1.
Tsubouchi K; Inoue S; Ibusuki R; Iwasaki T; Harada T
Respirol Case Rep; 2020 Apr; 8(3):e00536. PubMed ID: 32148838
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
Calthorpe L; Romero-Hernandez F; Miller P; Conroy PC; Hirose K; Kim A; Kirkwood K; Nakakura E; Corvera C; Maker AV; Alseidi A; Adam MA
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612225
[TBL] [Abstract][Full Text] [Related]
14. Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology data.
Eastwood M; Marc ST; Gao X; Sailem H; Offman J; Karteris E; Fernandez AM; Jonigk D; Cookson W; Moffatt M; Popat S; Minhas F; Robertus JL
Artif Intell Med; 2023 Sep; 143():102628. PubMed ID: 37673586
[TBL] [Abstract][Full Text] [Related]
15. Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma.
Kim RY; Mitra N; Bagley SJ; Marmarelis ME; Haas AR; Rendle KA; Vachani A
JTO Clin Res Rep; 2021 Jun; 2(6):100188. PubMed ID: 34590032
[TBL] [Abstract][Full Text] [Related]
16. Gluteal muscle metastases from malignant pleural mesothelioma: a case report.
Stirpe E; Bardaro F; Köhl J
Monaldi Arch Chest Dis; 2024 May; ():. PubMed ID: 38722058
[TBL] [Abstract][Full Text] [Related]
17. A challenging diagnosis of malignant mesothelioma with osteosarcomatous differentiation metastasizing to bone.
Brown M; Jersmann H; Crowhurst T; Van Vliet C; Crouch G; Badiei A
Respirol Case Rep; 2020 Nov; 8(8):e00664. PubMed ID: 32995012
[TBL] [Abstract][Full Text] [Related]
18. Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma.
Vita E; Stefani A; Di Salvatore M; Chiappetta M; Lococo F; Margaritora S; Tortora G; Bria E
J Clin Med; 2021 May; 10(11):. PubMed ID: 34070352
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid malignant pleural mesothelioma in lung tip: A case report.
Zou L; Cui X; Li Q
Asian J Surg; 2024 May; ():. PubMed ID: 38734557
[No Abstract] [Full Text] [Related]
20. [Morphological diagnostics of malignant pleural mesothelioma].
Junker K; Müller KM
Pathologe; 2014 Nov; 35(6):586-90. PubMed ID: 25304423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
